The Food and Drug Administration meets next week to review a closely watched drug for ALS, or Lou Gehrig’s disease, following months of lobbying by patient groups and congressional lawmakers
Related posts
-
Game time: Dave & Buster’s to open at Yorktown Center
Dave & Buster’s is scheduled to open next month at Yorktown Center in Lombard with the... -
Hanover Park parks president speaking out on citation for verbal assault of teen referee
Hanover Park Park District President Mark Elkins is speaking out regarding a Carol Stream citation he... -
Five high school football games to watch this weekend
St. Charles North (3-0) at Batavia (3-0)